Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Statement

9 Apr 2020 07:00

RNS Number : 2822J
First Derivatives PLC
09 April 2020
 

9 April 2020

 

First Derivatives plc

("FD" or the "Group")

 

Trading Update and Notice of Results

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that it continued to trade positively in the second half of the financial year ended 29 February 2020. As a result, the Board expects to report a financial performance in line with company-compiled consensus forecasts of £241m of revenue and £46m of adjusted EBITDA. Net debt at the period end was £50m, which was better than the consensus forecast of £56m.

 

COVID-19

 

The global operations of the Group enabled us to identify the business disruption threat of COVID-19 early, and we implemented our pandemic plan at the beginning of February across all regions in which we operate. A team led by CEO Seamus Keating and comprising senior leaders across FD coordinated the action, with the priorities of protecting the health and wellbeing of our employees and supporting our customers.

 

In FinTech, the Group supports mission-critical systems across the financial industry and in other markets our technology is key to the success of our customers. We contacted all our customers to minimise the impact of COVID-19 through various measures including remote working and are pleased that these are working without significant disruption to the business.

 

Impact to date

 

To date we have seen no financial impact from the effects of COVID-19. All our services delivery is now being conducted remotely, with no impact on revenue. In our managed services and consulting business the services that we provided prior to COVID-19 are now being delivered remotely with utilisation rates in March 2020 remaining in line with the prior month. We continue to monitor developments closely through close and regular contact with customers across all the markets in which we operate.

 

Potential impacts and mitigation

 

Looking ahead, our conversations with customers indicate that in the near-term there will be a lengthening of software sales cycles, at least until the impact of COVID-19 is clearer. The Group is protected to some extent by the breadth of its sales pipeline across multiple industries and geographies, while further reassurance is provided by the repeat and recurring nature of the majority of our software revenue.

 

In consulting and managed services, we continue to benefit from high levels of repeat revenue from the 'Business as Usual' operations of our capital markets clients. We are monitoring the impact of COVID-19 on new business, particularly with regard to project work implementing change programs.

 

As the macroeconomic impact of COVID-19 continues to grow, the Group has conducted a scenario testing exercise with a range of assumptions including a severe, extended downturn in economic activity. Under all such scenarios the Group remains profitable and cash generative.

 

Notwithstanding the assurance provided by our scenario testing, the Group has taken a range of measures to mitigate any future potential impact of COVID-19, including suspending non-essential business travel and short-term deferral of the summer graduate intake. In addition, the Executive Directors will not receive a bonus payment relating to the financial year ended 29 February 2020.

 

In order to preserve the Group's liquidity during this period, the Board will not recommend a final dividend in respect of the year to 29 February 2020.

 

Liquidity

 

As at 31 March 2020, FD had gross cash available to it of £64m. This included £35m of funds drawn down on 24 March 2020 from the Group's available finance facilities, with the funds placed on deposit to provide further comfort on liquidity should conditions deteriorate markedly. The Group has a further £15m in undrawn revolving credit facilities available to it.

 

The Group has significant headroom on its covenants and taking into account the scenario testing and mitigating measures taken, expects that situation to persist through the impact of COVID-19, irrespective of its duration.

 

The strength of our business model and liquidity position provide us with the confidence to continue to invest across the Group, in line with our strategy.

 

Summary

 

The Group delivered continued solid growth in the financial year to 29 February 2020. We reacted quickly to help employees and customers minimise the impact of COVID-19. While there has been no financial impact to date, it is still too early to determine what impact may result, particularly if there is an extended period of economic disruption. We believe that the Group has acted prudently to mitigate any potential impact through a range of measures aimed at ensuring its ongoing financial liquidity.

 

In the longer term, FD remains confident in its strategy and in particular the growth in demand for its world-class Kx technology from both potential customers and partners.

 

Date of results

 

The Group will announce its full year results for the year ended 29 February 2020 on 19 May 2020. A briefing for analysts and investors will be held on the day and further details will be provided in due course.

 

Enquiries

For further information please contact:

 

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

 

+353 1 667 0420

 

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0)20 3727 1000

 

 

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, utility, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERSRITIII
Date   Source Headline
2nd Jul 20187:02 amRNSFD to buy out minority Kx Systems shareholders
29th Jun 201811:32 amRNSTotal Voting Rights
27th Jun 20181:03 pmRNSAGM Statement
15th Jun 20186:01 pmRNSHolding(s) in Company
8th Jun 20188:00 amRNSEnterprise Securities Market Notice
7th Jun 201810:43 amRNSHolding(s) in Company
5th Jun 20184:51 pmRNSNotice of AGM
1st Jun 20184:14 pmRNSIssue of Equity
22nd May 20187:00 amRNSPreliminary results for the year ended 28 Feb 2018
17th May 20187:02 amRNSKx provides rapid access to unstructured data
25th Apr 20187:00 amRNSTrading update and Notice of Results
3rd Apr 201810:00 amRNSTotal Voting Rights
23rd Mar 20187:00 amRNSEnterprise Securities Market Notice
19th Mar 201810:09 amRNSIssue of Equity
28th Feb 20189:01 amRNSTotal Voting Rights
20th Feb 20187:00 amRNSContract Win in Gaming
7th Feb 20187:00 amRNSEnterprise Securities Market Notice
1st Feb 20185:23 pmRNSIssue of Equity
31st Jan 20183:40 pmRNSTotal Voting Rights
15th Jan 20187:00 amRNSAppointment of Non-Executive Director
4th Jan 20187:00 amRNSEnterprise Securities Market Notice
29th Dec 20177:00 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSIssue of Equity
19th Dec 20174:06 pmRNSDirector/PDMR Shareholding
18th Dec 20174:07 pmRNSIssue of Equity
14th Dec 20177:00 amRNSEnterprise Securities Market Notice
11th Dec 20177:00 amRNSTelco Acquisition
7th Dec 20177:00 amRNSEnterprise Securities Market Notice
1st Dec 20174:31 pmRNSIssue of Equity
30th Nov 20178:36 amRNSTotal Voting Rights
22nd Nov 201710:35 amRNSHolding(s) in Company
21st Nov 20174:54 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSEnterprise Securities Market Notice
10th Nov 201712:32 pmRNSIssue of Equity and Dividend Timetable Amendment
7th Nov 20177:00 amRNSHalf Yearly Report
6th Nov 20177:00 amRNSKx selected by Red Bull Racing
13th Oct 20177:00 amRNSNotice of Results
2nd Oct 20179:09 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSMajor Machine Learning Investment in Kx Technology
5th Sep 20177:00 amRNSEnterprise Securities Market Notice
30th Aug 20173:04 pmRNSIssue of Equity
23rd Aug 201712:20 pmRNSHolding(s) in Company
31st Jul 201711:58 amRNSTotal Voting Rights
28th Jul 20177:00 amRNSEnterprise Securities Market Notice
25th Jul 20177:00 amRNSHolding(s) in Company
24th Jul 20174:26 pmRNSIssue of Equity from exercise of Share Options
7th Jul 20177:00 amRNSEnterprise Securities Market Notice
3rd Jul 20174:23 pmRNSIssue of Equity from exercise of Share Options
30th Jun 201710:48 amRNSTotal Voting Rights
23rd Jun 20171:50 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.